Best medication for osteoporosis, honestly
Osteoporosis medication is about preventing a fracture you cannot feel coming, which makes both the choice of drug and the way it is taken unusually important. Below is each option, who it fits, the practical demands of each, and our recall-safety rating.
Two things that decide whether treatment works
First, oral bisphosphonates only work if taken exactly as directed: on an empty stomach with a full glass of plain water, and staying upright without food or other drugs for at least 30 minutes. Skipping that ritual means very little drug is absorbed and can cause oesophageal irritation. Second, denosumab (Prolia) must not simply be stopped — discontinuing it without transitioning to another drug causes a rebound of bone loss and a real risk of multiple spinal fractures. Both facts matter more than which drug is nominally 'strongest'.
Alendronate (Fosamax)
Bisphosphonate
The most-used first-line option: a weekly tablet with strong fracture-prevention evidence and a very low price. Its demands are the dosing ritual — empty stomach, plain water, stay upright 30 minutes — and it is unsuitable if you cannot sit or stand upright, or have certain oesophageal problems. Low blood calcium must be corrected BEFORE starting — that is a contraindication for every bisphosphonate on this page, not only for denosumab.
Alendronate (generic)
Bisphosphonate
The inexpensive generic of the same first-line drug, and how it is usually dispensed.
Zoledronic acid (Reclast)
Bisphosphonate (IV)
A once-yearly intravenous infusion — the answer when tablets are not tolerated, absorbed, or reliably taken. A flu-like reaction for a day or two after the first infusion is common and usually mild. It is CONTRAINDICATED if creatinine clearance is under 35 mL/min or kidney function is acutely worsening, because it can cause kidney failure — and kidney function is measured before EVERY yearly infusion, not just the first. Low blood calcium must be corrected first.
Risedronate (Actonel)
Bisphosphonate
An alternative oral bisphosphonate with similar evidence; some formulations have slightly easier food requirements, which occasionally makes it a better practical fit. Its restrictions are its own, not merely alendronate's: contraindicated with oesophageal narrowing or achalasia, if you cannot stay upright for 30 minutes, or with uncorrected low calcium — and not recommended below a creatinine clearance of 30 mL/min.
Ibandronate (Boniva)
Bisphosphonate
A monthly tablet option with good evidence for spine fracture reduction, but weaker evidence at the hip than alendronate or zoledronic acid — which is why it is less often the first pick. Its dosing rule is also stricter: 60 minutes upright with nothing by mouth, contraindicated rather than merely inconvenient if you cannot manage it, as are oesophageal narrowing and uncorrected low calcium; not recommended below a creatinine clearance of 30 mL/min. That is double the 30 minutes required for alendronate or risedronate.
How to choose
The honest way to narrow it down — matched to your situation, not a ranking. These are common scenarios, not a complete rulebook; the final choice is a prescriber’s.
- Standard first treatment after a diagnosis
- An oral bisphosphonate — alendronate weekly is the usual choice, cheap and well evidenced.
- You can't manage the upright/empty-stomach routine, or tablets upset you
- Once-yearly intravenous zoledronic acid (Reclast) removes the adherence problem entirely.
- You have significant kidney impairment
- Bisphosphonates may be unsuitable — but denosumab is NOT a simple substitute here: it carries an FDA boxed warning for severe, sometimes fatal hypocalcaemia in advanced CKD (eGFR under 30, including dialysis). Any choice in this situation is a specialist decision with calcium corrected and monitored first.
- You have very high fracture risk or have already fractured on treatment
- Bone-building (anabolic) therapy is considered, given first and then followed by an antiresorptive — a specialist pathway.
- You are on denosumab and want to stop
- Never simply stop — a transition to a bisphosphonate must be planned, or rebound spinal fractures can follow.
Osteoporosis medications at a glance
| Medication | Type | How often | Practical demands | Key caution |
|---|---|---|---|---|
| Alendronate (Fosamax) | Oral bisphosphonate | Weekly | Empty stomach, water, upright 30 min | Oesophageal irritation if ritual skipped |
| Risedronate (Actonel) | Oral bisphosphonate | Weekly/monthly | Similar ritual | Comparable to alendronate |
| Ibandronate (Boniva) | Oral bisphosphonate | Monthly | Upright 60 min (double the others) | Weaker hip-fracture evidence |
| Zoledronic acid (Reclast) | IV bisphosphonate | Yearly infusion | Clinic visit; kidney check | Flu-like reaction after first dose |
| Denosumab (Prolia) | RANKL inhibitor | Injection every 6 months | Must not lapse | BOXED WARNING: severe hypocalcaemia in advanced CKD; rebound vertebral fractures if stopped |
What to expect
Osteoporosis treatment is silent — you will not feel it working, and the benefit is a fracture that does not happen. Progress is tracked with a DXA bone-density scan, usually repeated after about one to two years, not by symptoms. Bisphosphonates keep working for a period after stopping, which is why prescribers often review after roughly three to five years and may pause treatment (a 'drug holiday') in lower-risk people — a decision that does not apply to denosumab, which must be transitioned rather than stopped. Adequate calcium and vitamin D support the medication and are checked alongside it, but do not substitute for it in someone with established osteoporosis.
When to get medical help
- New or worsening heartburn, chest pain, or pain on swallowing after an oral bisphosphonate — possible oesophageal irritation or ulcer; stop and contact your prescriber.
- New thigh or groin pain, especially a dull ache that builds over weeks — a rare atypical femoral fracture warning sign after long-term treatment; get it imaged.
- Jaw pain, loose teeth, or non-healing gum or jaw sores, particularly after dental surgery — rare osteonecrosis of the jaw; tell your dentist and prescriber you take these drugs.
- Stopping denosumab without a planned replacement — rebound bone loss and multiple spinal fractures can follow; do not let a dose lapse.
- On denosumab with advanced kidney disease: numbness or tingling around the mouth or in the hands and feet, muscle cramps or spasms, or confusion — possible severe hypocalcaemia, the subject of its FDA boxed warning. Seek urgent care.
- Sudden back pain, loss of height, or a stooped posture — possible vertebral fracture; needs assessment.
- Tingling around the mouth or in the hands and feet, cramps, spasms or confusion on ANY of these drugs — possible low blood calcium, which every bisphosphonate contraindicates if uncorrected, not just denosumab.
- Passing much less urine, swelling, or feeling very unwell in the days after a zoledronic acid infusion — possible acute kidney injury.
Frequently asked questions
What is the best medication for osteoporosis?
For most people it is an oral bisphosphonate — alendronate weekly is the usual first choice, with strong evidence for reducing spine and hip fractures and a very low cost. Zoledronic acid, a once-yearly infusion, is the practical alternative when tablets are difficult, and denosumab is used in some situations including kidney impairment. Very high-risk patients may be given a bone-building drug first. The best drug is the one you will actually take correctly.
How do you take alendronate correctly?
First thing in the morning, on an empty stomach, with a full glass of plain water — not coffee, juice or mineral water — and then stay fully upright, without eating, drinking or taking other medicines, for at least 30 minutes. Very little of the drug is absorbed otherwise, and lying down soon after can cause oesophageal irritation or ulceration. The routine is not optional; it is what makes the drug work.
Can you stop osteoporosis medication after a few years?
Sometimes, for bisphosphonates. Because they persist in bone after stopping, prescribers often reassess after about three to five years and may pause treatment in people whose risk has fallen — the so-called drug holiday — while continuing in those at high risk. This does NOT apply to denosumab, which must be transitioned to another drug rather than stopped, because of rebound fracture risk.
What happens if you stop Prolia (denosumab)?
Stopping denosumab without follow-on treatment causes a rapid rebound in bone turnover and a documented risk of multiple vertebral fractures, sometimes within months. (Separately, denosumab carries an FDA boxed warning for severe hypocalcaemia in people with advanced kidney disease, so calcium must be corrected and monitored in that group.) That is why doses should not be delayed or skipped, and why coming off it always involves transitioning to a bisphosphonate under medical supervision. It is one of the clearest 'do not just stop' situations in medicine.
Do bisphosphonates cause jaw problems?
Osteonecrosis of the jaw is a real but rare complication, and it is far more common at the high doses used in cancer care than at osteoporosis doses. The practical advice is to keep your dentist informed that you take the drug, deal with major dental work before starting where possible, and report jaw pain, loose teeth or non-healing sores. For most people at osteoporosis doses the fracture-prevention benefit substantially outweighs this risk.
Are calcium and vitamin D enough on their own?
Not for established osteoporosis. Adequate calcium and vitamin D are the foundation that lets the medication work properly and are checked alongside treatment, but in someone with osteoporosis or a fragility fracture they do not reduce fracture risk anywhere near as much as drug treatment does. They complement it rather than replace it.
Guides for these medications
Sources
Treatment-role framing follows standard US clinical guidelines; each drug links to its FDA label and our rating. This is general reference information, not medical advice, and not a recommendation to take any drug — the choice is a decision to make with a clinician. If you are in crisis, call or text 988 (the US Suicide & Crisis Lifeline).